Summary
6-OHDA (6 or 8 µg) unilaterally applied into the ventrolateral striatum induces neurotoxic effects which lead to unilateral hyperactivity triggering contralateral turning and rotations after apomorphine administration. Treatment with alpha-tocopherol prevents the hypersensitive reaction. The sensitivity of the cerebral tissue to apomorphine following 6-OHDA treatment is enhanced when 7.5 µg FeCl3 is coadministered with 6-OHDA. Only when the combination of 6-OHDA and FeCl3 is administered the escape latency to find a hidden platform in a water maze-test increased as measured 12 weeks later. The night activity of such treated animals was markedly reduced. Remarkable effects of unilaterally applied FeCl3 (0.06–1.5 ug) were observed in old rats, and in rats after transient cerebral oligemia. Apomorphine treatment to such animals induced rotations. It is possible, therefore, that mild to moderate transient or permanent local oxygen deficits together with iron cause progressive damage to vulnerable cerebral tissue. Such an effect would be comparable to the neurotoxicity of 6-OHDA possibly involve free radicals and lipid peroxidation.
On leave: Institute of Pharmacology, Polish Academy of Science, Krakow, Poland
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe K, Yuki S, Kogure K (1988) Strong attenuation of ischemic and post ischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 480–485
Akiyama Y, Akihiro I, Koshimura K, Ohue T, Yamagata S, Miwa S, Kikuchi H (1991) Effect of transient forebrain ischemia and reperfusion on function of dopaminergic neurons and dopamine reuptake in vivo rat striatum. Brain Res 561: 120–127
Asano T, Johshita H, Koide T, Takakura K (1984) Amelioration of ischaemic cerebral oedema by a free radical scavenger, AVS: 1.2-bis (nicotinamido)propane. An experimental study using a regional ischemia model in cats. Neurol Res 6: 163–168
Ben-Schachar D, Youdim MBH (1991) Intranigral iron injection induces behavioural and biochemical “Parkinsonism” in rats. J Neurochem 57: 2133–2135
Betz AL (1990) Effect of the free radical scavenger dimethylthiourea in experimental cerebral ischemia. In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia 1990. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 335–342
Block F, Sieklucka M, Schmidt-Kastner R, Heim C, Sontag KH (1993) Metabolic changes during and after transient clamping of carotid arteries in normotensive rats. Brain Res Bull 31: 91–96
Boisvert DPJ, Schreiber C (1992) Interrelationship of excitotoxic and free radical mechanisms. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 311–320
Braughler JM, Hall ED (1989) Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Rad Biol Med 6: 289–301
Bullock R, Graham DI, Chen MH, Lowe D, McCulloch J (1990) Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPPene. J Cereb Blood Flow Metab 10: 668–674
Cadet JL, Ratz M, Jackson-Lewis V, Fahn S (1989) Vitamine E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioural and biochemical evidence. Brain Res 476: 10–15
Clemens JA, Phebus LA (1988) Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci 42: 707–713
Cohen G (1984) Oxyradical toxicity in catecholamine neurons. Neurotoxicology 5: 82–88
Cohen G, Heikkila RE (1974) The generation of hydrogen peroxide, superoxide radical, and hydroradical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249: 2447–2452
Cohen G, Heikkila RE, Allis B, Cabbat F, Demblec D, McNamee D, Mytilineau C, Winston B (1976) Destruction of sympathetic nerve terminals by 6hydroxydopamine: protection by 1-phenyl-3-(2-thiaxolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol, and n-butanol. J Pharmacol Exp Ther 199: 336–352
Cools AR (1981) Aspects and prospects of the concept of neurochemical and cerebral organisation of aggression: introduction of new research strategies in “brain and behaviour” studies. In: Brain PF, Bendton D (eds) Biology of aggression. Fythoff and Noordhoff
Cools AR, Brachten R, Heeren D, Willeman A, Ellenbroek BJ (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24: 49–69
Damsma G, Boisvert DP, Mudrick LA, Wenkstern D, Fibiger HC (1990) Effects of transient forebrain ischemia and pargyline on extra-cellular concentrations of dopamine, serotonine, and their metabolites in the rat striatum as determined by in vivo microdialysis. J Neurochem 54: 801–808
Diemer NH, Balchen T, Hu P, Frank L, Bruhn T, Berg M, Christensen T, Jorgensen MB, Johansen FF (1992) The effect of AMPA anagonists on the regional neuron loss after cerebral ischemia in the rat. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 121–127
Dunnet SB, Iversen SD (1982) Spontaneous and drug-induced rotation following localized 6-hydroxydopamine and kainic acid-induced lesions of the neostriarum. Neuropharmacology 22: 899–908
Flamm ES, Demopoulos HB, Seligman ML, Poser R, Pietronigro DD, Ransohoff J (1978) Free radicals in cerebral ischemia. Stroke 9: 445–447
Ginsberg MD, Graham DI, Busto P (1985) Regional glucose utilization and blood flow following grated forebrain ischemia in the rat: correlation with neuropathology. Ann Neurol 18: 470–481
Ginsberg MD, Takagi K, Globus MY-T (1992) Release of neurotransmitters in the cerebral ischemia: relevance to neuronal injury. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 177–189
Globus MYT, Busto R, Dietrich WD, Martinez E, Valdez I, Ginsberg MD (1988) Effect of ischemia on the in vitro release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem 51: 1455–1464
Graybiel A (1990) Neurotransmitters and neuromodulators in the basal ganglia. TINS 13: 244–254
Haba K, Ogawa N, Mizukawa K, Mori A (1991) Time course of changes in lipid peroxidation, pre-and postsynaptic cholinergic indices, NMDA receptor binding and neuronal death in the gerbil hippocampus following transient ischemia. Brain Res 540: 116–120
Hall ED (1990) Lazaroids. Efficacy and anti-oxidant mechanism in experimental cerebral ischemia. In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia 1990. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 343–350
Hall ED, Yonkers PA (1988) Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 19: 340–344
Hall ED, Braughler JM (1989) Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for the involvement of oxigen free radicals and lipid peroxidation. Free Rad Biol Med 6: 303–313
Halliwell B (1978) Biochemical mechanisms accounting for the toxic action of oxygen in living organisms: the key role of superoxid dismutase. Cell Biol Int Rep 2: 113–128
Halliwell B, Gutteridge JMC (1984) Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet is 1396
Halliwell B, Gutteridge JMC (1985) Oxygen radicals and the nervous system. Trends Neurosci 8: 22–26
Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medicine, 2nd edn. Oxford University Press, pp 86–276
Ito T, Kawakami M, Yamauchi Y (1986) Effect of allopurinol on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats. Stroke 17: 1284–1287
Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology. Ann Rev Neurosci 3: 169–187
Kirsch JR, Phelan AM, Lange DG, Traystman RJ (1987) Reperfusion induced
free radical formation following global ischemia. Ped Res 21: 202A
König J, Klippel R (1963) The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams and Wilkins, Baltimore
Kogure K, Arai H, Abe K, Nakano M (1985) Free radical damage of the brain following ischemia. Prog Brain Res 63: 237–259
Kurumaji A, Nehls DG, Park CK, McCulloch J (1989) Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Brain Res 496: 268–284
Läer S, Hither G, Block F, Sontag KH (1992) Acute reduction of cerebral blood flow by clamping of both carotid arteries increases dopamine release. 4th International Symposium on Pharmacology of Cerebral Ischemia, Marburg, p 67 (Abstract)
Läer S, Block F, Hither G, Heim C, Sontag KH (1993) Effect of transient reduction of cerebral blood flow in normotensive rats on striatal dopamine release. J Neural Transm [Gen Sect] 92: 203–211
Lekieffre D, Ghribi O, Callebert J, Allix M, Plotkine M, Boulu RG (1992) Effect of kynurenic acid on ischemia-induced glutamate accumulation in the hippo-campus during four-vessel occlusion. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 105–112
Lewin G (1985) Clinical trial for Parkinson’s disease. Science 230: 527–528
Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY (1989) Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 256: H589–H593
Lippert K, Welsch M, Krieglstein J (1992) The neuroprotective effect of combined treatment with dizocilpine and NBQX in vitro and in vivo. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 147–153
Martz D, Rayos G, Schielke GP, Betz AL (1989) Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in the rat. Stroke 20: 488–494
Meldrum BS (1990) Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metabol Rev 2: 27–57
Meldrum BS, Moncada C, Lekieffre D, Arvin B, Smith S (1992) Strategies for cerebraprotection: post-synaptic glutamate antagonism versus inhibition of ischemia-induced glutamate release. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 115–119
Melzacka M, Weiner N, Heim C, Sontag RH, Wesemann W (1992) Effect of transient reduction of cerebral blood flow on membrane anisotropy and lipid peroxidation in different brain areas. 4th International Symposium on Pharmacology of Cerebral Ischemia, Marburg, p 31 (Abstract)
Moncada C, Arvin B, Lekieffre D, Chapman A, Meldrum BS (1992) The nonNMDA anagonist GYKI 52466 inhibits glutamate release induced by transient severe forebrain ischemia in rat striatum. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 155–159
Obrenovitch TP, Sarna GS, Matsunoto T, Symon L (1990) Extracellular striatal dopamine and its metabolites during transient cerebral ischemia. J Neurochem 54: 1526–1532
Oh SM, Betz AL (1992) Interaction between radicals and excitatory amino acids in the formation of ischemic brain edema in rats. Stroke 22: 915–921
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
Persson L, Bolander H, Hillered L, Hardemark HG, Olsson Y, Ponten U (1989) Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke 20: 641–645
Phebus LA, Clemens JA (1989) Effects of transient global, cerebral ischemia on striatal extracellular dopamine, serotonine and their metabolites. Life Sci 19: 1335–1342
Pulsinelli WA, Brierley JB, Plum F (1982) Temporal profile of neuronal damage in a model of forebrain ischemia. Ann Neurol 11: 491–498
Ragsdale CW Jr, Graybiel AM (1990) A simple ordering of neo-cortical areas established by the compartmental organization of their striatal projections. Proc Natl Acad Sci USA 87: 6196–6199
Rothman SM, Olney JW (1986) Glutamate and the pathophysiology of hypoxic ischemic brain damage. Ann Neurol 19: 105–111
Sengstock GJ, Olanow CW, Dunn AJ, Arendash GW (1992) Iron induces degeneration of nigrostriatal neurons. Brain Res Bull 28: 645–649
Sheardown MJ, Hansen AJ, Eskesen K, Suzdak P, Diemer NH, Honore T (1990) Blockade of AMPA receptors in the CA1 region of the hippocampus prevents ischemia induced cell death. In: Krieglstein J, Oberpichler H (eds) Pharmacology of cerebral ischemia 1990. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 245–253
Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990) 2,3Dihydroxy-6-nitro-7-sulfamyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247: 571–574
Siesjö BS (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1: 155–158
Siesjö BK (1989) Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1: 165–211
Siesjö BK, Katsura K, Pahlmark K, Smith ML (1992) The multiple causes of ischemic brain damage: a speculative synthesis. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 511–525
Sontag KH, Heim C, Block F, Sieklucka M, Schmidt-Kastner R, Melzacka M, Osborne N, Läer S, Hüther G, Kunkel M, Ulrich F, Bortolotto Z, Weiner N, Wesemann W (1992) Cerebral oligemic hypoxia and forebrain ischemia — common and different long-lasting consequences. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 471–479
Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamineinduced degeneration of nigrostriatal dopamine system. Acta Physiol Scand [Suppl] 367: 69–93
Wahl F, Allix M, Plotkine M, Boulu RG (1992) Riluzole reduces infarct size induced by focal cerebral ischemia. In: Krieglstein J, Oberpichler-Schwenk H (eds) Pharmacology of cerebral ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 167–174
Watson BD, Ginsberg MD (1989) Ischemic injury in brain: role of oxygen radical-mediated processes. In: Barkai A, Baran NG (eds) Arachidonic acid in the nervous system. Physiological and pathological significance. Ann NY Acad Sci 559: 269–281
Weinberger J, Nieves-Rosa J, Cohen G (1985) Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-para-tyrosine. Stroke 16: 864–870
Whishaw IQ (1987) Hippocampal granule cell and CA 3–4 lesions impair formation of a place learning set in the rat and induce reflex epilepsy. Behav Brain Res 24: 59–72
Whishaw IQ, Dunnett SB (1985) Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues. Behav Brain Res 18: 11–29
Yamamoto M, Shima T, Uozumi T, Sogabe T, Yamada K, Kawasaki T (1983) A possible role of lipid peroxidation in cellular damages caused by cerebral ischemia and the protective effect of tocopherol administration. Stroke 14: 977–982
Yoshida S, Abe K, Busto R, Watson BD, Kogure K, Ginsberg MD (1982) Influence of transient ischemia on lipid-soluble antioxidants, free fatty acids and energy metabolites in rat brain. Brain Res 245: 307–316
Young W, Wojak JC, DeCresito V (1988) 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke 19: 1013–1019
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag/Wien
About this paper
Cite this paper
Heim, C., Kolasiewicz, W., Jaros, T., Sontag, KH. (1993). Consequences of intrastriatally administrated FeCl3 and 6-OHDA without and after transient cerebral oligemia on behaviour and navigation. In: Riederer, P., Youdim, M.B.H. (eds) Iron in Central Nervous System Disorders. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9322-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9322-8_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82520-4
Online ISBN: 978-3-7091-9322-8
eBook Packages: Springer Book Archive